Authors: Sigvardson, KW Adams, SP Barnes, TB Blom, KF Fortunak, JM Haas, MJ Reilly, KL Repta, AJ Nemeth, GA

Citation: Kw. Sigvardson et al., The isolation and identification of a toxic impurity in XP315 drug substance, J PHARM B, 27(1-2), 2002, pp. 327-334

Authors: Buckley, D Haas, MJ Scholz, TH Sigvardson, KW

Citation: D. Buckley et al., Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777, J PHARM B, 24(4), 2001, pp. 651-657

Authors: Williams, RC Riley, CM Sigvardson, KW Fortunak, J Ma, P Nicolas, EC Unger, SE Krahn, DF Bremner, SL

Citation: Rc. Williams et al., Pharmaceutical development and specification of stereoisomers, J PHARM B, 17(6-7), 1998, pp. 917-924